Healio
›
Hematology/Oncology
›
Education Lab/CME
Personalize your page!
Register for Healio to get content tailored to your specialty and areas
of interest. It’s FREE and only takes one minute.
Register now!
- VIDEO
- March 1, 2012
- We caught up with leading experts and attendees during the San Antonio Breast Cancer Symposium to discuss some of the biggest issues surrounding breast cancer this year…
- CME
- December 10, 2011
- Limited treatment options are available for metastatic sarcoma. This monograph will review inhibition of the mTOR pathway, a promising therapeutic rationale currently in development for the… More »
- Credit Type(s): CME | Credit: 1.25
- December 1, 2011
- Effective communication between health care providers and patients diagnosed with cancer is an essential part of the treatment process. Communicating effectively ensures the patient is an active…
- CMEVIDEO
- November 18, 2011
- Immunotherapy is emerging as a promising approach to the treatment of non-small cell lung cancer (NSCLC), which has had generally limited options with poor survival rates. Stimulating the patient’s… More »
- Credit Type(s): CME | Credit: 1.5
- CME
- November 11, 2011
- Advances in the treatment of non-small cell lung cancer over the past several decades have achieved modest improvements in response and survival, but overall prognosis for patients with advanced… More »
- Credit Type(s): CME / CNE | Credit: 0.75
- CME
- October 25, 2011
- Immunotherapy is emerging as a promising approach to the treatment of non-small cell lung cancer (NSCLC), which has had generally limited treatment options with poor survival rates. Antibodies… More »
- Credit Type(s): CME / CNE | Credit: 1.25
- CME
- October 12, 2011
- Metastatic sarcoma describes a range of disease that have poor prognosis and limited options for treatment. For most patients, the available medications have significant toxicity, and even for… More »
- Credit Type(s): CME | Credit: 0.75
- CME
- October 10, 2011
- Controversy regarding the appropriate dose and duration of adjuvant interferon (IFN) therapy for patients with high-risk melanoma persists due to conflicting results of clinical trials. This… More »
- Credit Type(s): CME | Credit: 1.25
- CME
- September 28, 2011
- Glioblastoma (GBM), the most common primary malignant brain tumor, historically has had an overall poor prognosis, despite surgical resection and external beam radiotherapy. The addition of… More »
- Credit Type(s): CME | Credit: 0.75
- CME
- September 25, 2011
- Immunotherapy is emerging as a promising approach to the treatment of non–small cell lung cancer (NSCLC), which has had generally limited options with poor survival rates. Stimulating the patient’s… More »
- Credit Type(s): CME | Credit: 1.25